Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
FDF
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 826-39-1
2. Inversine
3. Mevasin
4. Mecamylamine (hydrochloride)
5. Mevasine
6. Mecamylamine Hcl
7. N,2,3,3-tetramethylbicyclo[2.2.1]heptan-2-amine Hydrochloride
8. Mecamylamine, Hcl
9. N,2,3,3-tetramethyl-2-norbornanamine Hydrochloride
10. Nsc-757086
11. Mecamylamine Hydrochloride [usp]
12. 4956djr58o
13. Bicyclo(2.2.1)heptan-2-amine, N,2,3,3-tetramethyl-, Hydrochloride
14. Mekamin Hydrochloride
15. Mecamine Hydrochloride
16. Mecamylamine Hydrochloride (usp)
17. Vecamyl
18. Sr-01000075329
19. Einecs 212-555-8
20. 3-methylaminoisocamphane Hydrochloride
21. 3-methylaminoisokamfan Chlorid [czech]
22. Inversin
23. N-methyl-dl-isobornylamine Hydrochloride
24. Inversene
25. N,2,2,3-tetramethylbicyclo[2.2.1]heptan-3-amine;hydrochloride
26. 3-methylaminoisokamfan Chlorid
27. Unii-4956djr58o
28. Cpdb 0059
29. Inversine (tn)
30. Mecamylamine Chloride
31. 2-norbornanamine, N,2,3,3-tetramethyl-, Hydrochloride
32. N-methyl-n-2,5-endomethylene-1,6,6-trimethylcyclohexylamine Hydrochloride
33. Atg-3
34. Schembl123951
35. Chebi:6707
36. Chembl1237082
37. Niosh/rb7466510
38. Agi-004
39. Atg-003
40. Dtxsid70896795
41. Hms1571o04
42. Pharmakon1600-01500374
43. Hy-b1395
44. Tox21_500841
45. Ccg-39679
46. Mfcd00151462
47. Nsc757086
48. Akos015963326
49. Asa 185/13
50. Lp00841
51. Mecamylamine Hydrochloride [mi]
52. Nsc 757086
53. 2-(methylamino)isocamphane Hydrochloride
54. Ncgc00094171-01
55. Ncgc00094171-02
56. Ncgc00094171-03
57. Ncgc00261526-01
58. Ac-19862
59. Ls-14021
60. Mecamylamine Hydrochloride [mart.]
61. Mecamylamine Hydrochloride [vandf]
62. Mecamylamine Hydrochloride [usp-rs]
63. Mecamylamine Hydrochloride [who-dd]
64. 2-[1,2,4]triazol-1-ylmethyl-benzoicacid
65. Db-056643
66. Cs-0013122
67. Eu-0100841
68. Ft-0603516
69. Ft-0670962
70. Ft-0670963
71. Ft-0670964
72. Rb74665100
73. D00611
74. M 9020
75. Mecamylamine Hydrochloride [orange Book]
76. Mecamylamine Hydrochloride [usp Monograph]
77. N,2,3,3-tetramethyl-2-norcamphanamine Hydrochloride
78. Q-201341
79. Sr-01000075329-1
80. Sr-01000075329-6
81. Q27259230
82. 2-(methylamino)-2,3,3-trimethylnorbornane Hydrochloride
83. Mecamylamine Hydrochloride 100 Microg/ml In Acetonitrile
84. N,2,3,3-tetramethylbicyclo[2.2.1]heptan-2-amine;hydrochloride
85. Norbornane, 2-(methylamino)-2,3,3-trimethyl-, Hydrochloride
86. Bicyclo[2.2.1]heptan-2-amine, N,2,3,3-tetramethyl-, Hydrochloride (1:1)
Molecular Weight | 203.75 g/mol |
---|---|
Molecular Formula | C11H22ClN |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 1 |
Rotatable Bond Count | 1 |
Exact Mass | 203.1440774 g/mol |
Monoisotopic Mass | 203.1440774 g/mol |
Topological Polar Surface Area | 12 Ų |
Heavy Atom Count | 13 |
Formal Charge | 0 |
Complexity | 197 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 3 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Mecamylamine hydrochloride |
Active Ingredient | Mecamylamine hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 2.5mg |
Market Status | Prescription |
Company | Nexgen Pharma |
2 of 2 | |
---|---|
Drug Name | Mecamylamine hydrochloride |
Active Ingredient | Mecamylamine hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 2.5mg |
Market Status | Prescription |
Company | Nexgen Pharma |
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Mecamylamine Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mecamylamine Hydrochloride, including repackagers and relabelers. The FDA regulates Mecamylamine Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mecamylamine Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Mecamylamine Hydrochloride supplier is an individual or a company that provides Mecamylamine Hydrochloride active pharmaceutical ingredient (API) or Mecamylamine Hydrochloride finished formulations upon request. The Mecamylamine Hydrochloride suppliers may include Mecamylamine Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Mecamylamine Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Mecamylamine Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Mecamylamine Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Mecamylamine Hydrochloride DMFs exist exist since differing nations have different regulations, such as Mecamylamine Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Mecamylamine Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Mecamylamine Hydrochloride USDMF includes data on Mecamylamine Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Mecamylamine Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Mecamylamine Hydrochloride suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Mecamylamine Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Mecamylamine Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Mecamylamine Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Mecamylamine Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Mecamylamine Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Mecamylamine Hydrochloride suppliers with NDC on PharmaCompass.
Mecamylamine Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Mecamylamine Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Mecamylamine Hydrochloride GMP manufacturer or Mecamylamine Hydrochloride GMP API supplier for your needs.
A Mecamylamine Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Mecamylamine Hydrochloride's compliance with Mecamylamine Hydrochloride specifications and serves as a tool for batch-level quality control.
Mecamylamine Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Mecamylamine Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Mecamylamine Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Mecamylamine Hydrochloride EP), Mecamylamine Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Mecamylamine Hydrochloride USP).
LOOKING FOR A SUPPLIER?